Trading Options with an Edge
Select Page

BHVN

Search by
TICKER SYMBOL

Biohaven Pharmaceutical Holding Company Ltd

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

135

-1.93

(-1.409%)

Volume:

904,140

52 week range:

57.7 - 139.66

Market Cap:

8.829B

Company Description:

Biohaven Pharmaceutical Holding Company Ltd. is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, Alzheimer's disease, and spinocerebellar ataxia; and MPO inhibition for multiple system atrophy and amyotrophic lateral sclerosis.